Home/ Stocks/ BMY

Bristol-Myers Squibb Co.

BMY XNYS

$54.70 +0.30 (+0.56%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$110.27B

About Bristol-Myers Squibb Co.

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 32.5K Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$48.19B	$7.05B	$3.47
FY 2025	$48.19B	$7.05B	$3.47
Q3 2025	$12.22B	$2.19B	$1.08
Q2 2025	$12.27B	$1.31B	$0.64

TickerDaily Coverage

Stock Market Today, April 19, 2026: Earnings Week Ahead Shapes Trading Strategy

Market News David Brooks · Apr 20, 2026

With mega-cap earnings dominating next week's calendar, the stock market today sets up for a...

Why Are These Stocks Making Massive Moves Before the Bell Today? Friday March 27, 2026 Pre-Market Movers

Market News Sarah Mitchell · Mar 27, 2026

Five major stocks are making significant moves in pre-market trading Friday, March 27, 2026. From...

Why Is Bristol-Myers Squibb Company Contingent Value Rights (CELGr) Stock Up 51.7% Today?

Penny Stocks Marcus Rivera · Mar 2, 2026

Bristol-Myers Squibb's contingent value rights (CELGr) exploded 51.7% to $0.1482 on massive 49,741...

View All Coverage →

Get BMY Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Bristol-Myers Squibb Co..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.